Exam 2 - Catecholamines Flashcards

1
Q

The rate-limiting enzyme in the synthesis of catecholamines is:

A

tyrosine hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the synthesis of catecholamines?

A

tyrosine, need tyrosine hydroxylase -> DOPA, needs AADC -> Dopamine, needs dopamine betahydroxylase -> norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

6-hyroxydopamine is a ________ used to ________.

A

neurotoxin, damage catecholamine neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Catecholamines

A

include dopamine, norepinephrine, and epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What transporter is responsible for the reuptake of catecholamines? What are the two types?

A
  • vesicular monoamine transporter (VMAT)
  • VMAT 1 and VMAT 2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Resperine

A
  • blocks reuptake of dopamine, blocks VMAT
  • lowers BP and has a sedative effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does the release of catecholamines cause?

A

an increase of locomotor activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does inactivation of catecholamines depend on?

A

1) reuptake by dopamine transporter and norepi. transporter
2) metabolic breakdown by enzymes COMT and MAO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does the breakdown of catecholamines by COMT and MAO cause?

A
  • dopamine gets turned into HVA
  • norepi gets turned into MHPG and VMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the nigrostriatal pathway?

A
  • originates in substantia nigra and goes to the caudate-putamen
  • play an important role in the control of movement
  • this pathway is damaged in parkinson’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Parkinson’s disease

A
  • neurodegenerative disease
  • occurs when the cells that produce dopamine (in substantia nigra) die
  • no cure; L-dopa can be offered to replace dopamine; inhibition of dopamine metabolism by MAO type B inhibitors; anticholinergics that block ACH to prevent tremors; surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the symptoms of Parkinsons?

A
  • M - muscle rigidity
  • I - impaired balance
  • S - slowness and stiffness
  • T - (resting) tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MPTP

A
  • neurotoxin that causes symptoms of parkinsons
  • causes a loss of neurons in the substantia nigra
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mesolimbic system

A
  • originates in the ventral tegmental area and travels to the nucleus accumbens
  • important in addiction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mesocortical system

A
  • originates in ventral tegmental area and projects to the cerebral cortex
  • important in addiction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain Olds and Milners experiment

A
  • identified the certain brain sites where direct electrical stimulation is reinforcing
17
Q

Dopamine receptors

A
  • metabotropic
  • D1 to D5
18
Q

What is the difference between the D1 and D2 receptors?

A
  • D1 increased CAMP synthesis
  • D2 decreased CAMP synthesis
19
Q

What are the dopamine agonists? What receptor do they affect?

A
  • apomorphine - D1 and D2
  • SKF 38393 - D1
  • quinpirole - D2 and D3
  • agonists cause an increase in activity, also caused by giving 6-OHDA
20
Q

Dopamine antagonists ________ locomotion. What is an example of a dopamine antagonist? What does high doses of this antagonist do?

A
  • decrease
  • haloperidol
  • catalepsy (waxy flexbility)
21
Q

Noradrenergic system

A
  • originates in the locus coeruleus and provides input to the cortex, limbic system, thalamus, and hypothalamus
22
Q

What is the role of the locus coeruleus?

A

vigilance/arousal

23
Q

Adrenergic receptors, what are the two subtypes? Which inhibit and enhance the release of CAMP?

A
  • metabotropic
  • alpha and beta
  • beta receptors enhance the synthesis of CAMP
  • alpha receptors inhibit the rate of CAMP
24
Q

Adrenergic agonists _________ arousal and eating behavior.

A

stimulate/increase

25
Q

Where are the neural mechanisms for eating located? What is responsible for responses in this area?

A
  • hippocampus, specifically the paraventricular nucleus
  • alpha 2 receptors
26
Q

What effect does norepi. have on eating?

A
  • induces eating